Clinical Indication

Mast Cell Activation Syndrome (MCAS)

Date of classification

July 2020


Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .